Fidelity Enhanced Mid Cap ETF (NYSEARCA:FMDE – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $41.46 and traded as high as $41.79. Fidelity Enhanced Mid Cap ETF shares last traded at $41.69, with a volume of 796,407 shares changing hands.
Fidelity Enhanced Mid Cap ETF Price Performance
The stock has a market capitalization of $8.53 billion, a P/E ratio of 20.20 and a beta of 0.93. The stock’s 50-day simple moving average is $41.46 and its 200 day simple moving average is $39.34.
Institutional Trading of Fidelity Enhanced Mid Cap ETF
A number of hedge funds have recently modified their holdings of FMDE. Oppenheimer & Co. Inc. bought a new stake in shares of Fidelity Enhanced Mid Cap ETF during the 3rd quarter worth about $614,000. Park Avenue Securities LLC bought a new position in Fidelity Enhanced Mid Cap ETF in the 3rd quarter valued at about $8,876,000. Verdence Capital Advisors LLC bought a new position in Fidelity Enhanced Mid Cap ETF in the 3rd quarter valued at about $5,366,000. National Wealth Management Group LLC bought a new position in Fidelity Enhanced Mid Cap ETF in the 3rd quarter valued at about $210,000. Finally, Flagship Harbor Advisors LLC lifted its position in Fidelity Enhanced Mid Cap ETF by 25.7% during the third quarter. Flagship Harbor Advisors LLC now owns 33,098 shares of the company’s stock worth $1,336,000 after acquiring an additional 6,759 shares during the last quarter.
Fidelity Enhanced Mid Cap ETF Company Profile
The Fidelity Enhanced Mid Cap ETF (FMDE) is an exchange-traded fund that mostly invests in mid cap equity. The fund is an actively managed fund that invests in US, mid-cap companies. Stock selection is based on computer-aided analysis, which chooses stocks belonging to the Russel Midcap Index. FMDE was launched on Dec 20, 2007 and is issued by Fidelity.
Recommended Stories
- Five stocks we like better than Fidelity Enhanced Mid Cap ETF
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Fidelity Enhanced Mid Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Enhanced Mid Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.
